AMGN - AMGEN INC
303.01
-1.670 -0.551%
Share volume: 3,258,824
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.34%
PREVIOUS CLOSE
CHG
CHG%
$304.68
5.08
0.02%
Summary score
59%
Profitability
70%
Dept financing
26%
Liquidity
27%
Performance
63%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.63%
Return on assets
3.07%
Return on sales
30.43%
Return on invested capital
5.33%
Total debt ratio
92.23%
Debt ratio change over timeo
18.13%
Current Ratio
1.75%
Quick Ratio
1.4%
Cash Position Ratio
0.86%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.13%
Return on sales
21.39%
Return on invested capital
0%
Total debt ratio
93.35%
Debt ratio change over timeo
0%
Current Ratio
1.32%
Quick Ratio
0.95%
Cash Position Ratio
0.47%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
1.66%
Return on sales
25.43%
Return on invested capital
0%
Total debt ratio
93.6%
Debt ratio change over time
0%
Current Ratio
1.26%
Quick Ratio
0.95%
Cash Position Ratio
0.52%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
243.92%
Return on assets
-20.69%
Return on sales
671.97%
Return on invested capital
0%
Total debt ratio
1813.49%
Debt ratio change over time
18.13%
Current Ratio
30.69%
Quick Ratio
24.06%
Cash Position Ratio
12.16%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMGN | ABBV | VRTX | GILD |
|---|---|---|---|---|
| Return on equity | 18.63% | 20.29% | 3.97% | 4.21% |
| Return on assets | 3.07% | 2.11% | 5.63% | 3.09% |
| Return on sales | 30.43% | 26.43% | 42.4% | 28.65% |
| Return on invested capital | 5.33% | 3.23% | 27.97% | 2.16% |
| Profitability | 59% | 53% | 80% | 38% |
| Total debt ratio | 92.23% | 91.54% | 24.37% | 67.38% |
| Debt ratio change over time | 18.13% | 32.88% | 0.01% | 116.87% |
| Dept financing | 29% | 32% | 7% | 43% |
| Current Ratio | 1.32% | 0.76% | 2.83% | 1.14% |
| Quick Ratio | 0.95% | 0.66% | 2.58% | 0.98% |
| Cash Position Ratio | 0.47% | 0.26% | 1.88% | 0.38% |
| Liquididy | 26% | 12% | 75% | 19% |
| Short-term ratios | AMGN | ABBV | VRTX | GILD |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -9.2% | -23.78% |
| Return on assets | 2.13% | 1% | 4.89% | 0.73% |
| Return on sales | 21.39% | 16.75% | 40.27% | 4.66% |
| Return on invested capital | 0% | 0% | -15.46% | -14.26% |
| Profitability | 74% | 16% | 50% | 7% |
| Total debt ratio | 93.35% | 95.8% | 26.26% | 67.42% |
| Debt ratio change over time | 0% | 0% | -0.91% | 8.62% |
| Dept financing | 24% | 25% | 7% | 43% |
| Current Ratio | 1.32% | 0.76% | 2.83% | 1.14% |
| Quick Ratio | 0.95% | 0.66% | 2.58% | 0.98% |
| Cash Position Ratio | 0.47% | 0.26% | 1.88% | 0.38% |
| Liquididy | 27% | 17% | 75% | 25% |